1-4 of 4
Elisabetta Pilotti
Close
Sort by
Journal Articles

Stable changes in CD4 + T lymphocyte miRNA expression after exposure to HIV-1

Fabio Bignami, Elisabetta Pilotti, Linda Bertoncelli, Paola Ronzi, Mariolina Gulli, Nelson Marmiroli, Giacomo Magnani, Marcello Pinti, Lucia Lopalco, Cristina Mussini, Roberta Ruotolo, Massimo Galli, Andrea Cossarizza, Claudio Casoli
Journal: Blood
Blood (2012) 119 (26): 6259–6267.
https://doi.org/10.1182/blood-2011-09-379503
Published: 2012
Includes: Supplemental data
Journal Articles

Postgenomic up-regulation of CCL3L1 expression in HTLV-2–infected persons curtails HIV-1 replication

Clinical Trials & Observations
Elisabetta Pilotti, Lisa Elviri, Elisa Vicenzi, Umberto Bertazzoni, Maria Carla Re, Sonia Allibardi, Guido Poli, Claudio Casoli
Journal: Blood
Blood (2006) 109 (5): 1850–1856.
https://doi.org/10.1182/blood-2006-07-036046
Published: 2006
Includes: Supplemental data
Journal Articles

The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2

Claudio Casoli, Andrea De Lerma Barbaro, Elisabetta Pilotti, Umberto Bertazzoni, Giovanna Tosi, Roberto S. Accolla
Journal: Blood
Blood (2004) 103 (3): 995–1001.
https://doi.org/10.1182/blood-2003-07-2503
Published: 2004
Journal Articles

Human T-cell leukemia virus type 2 induces survival and proliferation of CD34 + TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-γ and granulocyte macrophage–colony-stimulating factor

Chiara Bovolenta, Elisabetta Pilotti, Massimiliano Mauri, Marco Turci, Paolo Ciancianaini, Paola Fisicaro, Umberto Bertazzoni, Guido Poli, Claudio Casoli
Journal: Blood
Blood (2002) 99 (1): 224–231.
https://doi.org/10.1182/blood.V99.1.224
Published: 2002